title: Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?
authors.affiliation: Department of Medicine, V. Cervello Hosptital, Palermo, Italy. salvomadonia.sm@gmail.com.
authors.forename: S
authors.initials: S
authors.lastname: Madonia
authors.affiliation: Department of Medicine, V. Cervello Hosptital, Palermo, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Orlando
authors.affiliation: Department of Medicine, V. Cervello Hosptital, Palermo, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Stagno
authors.affiliation: Department of Medicine, V. Cervello Hosptital, Palermo, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Cannizzaro
authors.affiliation: Department of Medicine, V. Cervello Hosptital, Palermo, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Madonia
authors.affiliation: Department of Medicine, V. Cervello Hosptital, Palermo, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Cottone
mesh_terms: D001663:Bilirubin; D005878:Gilbert Disease; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D012254:Ribavirin; D001663:Bilirubin